InVivoMAb anti-mouse CD31 (PECAM-1)

Chojnacki A, Wojcik K, Petri B, et al. Intravital imaging allows real-time characterization of tissue resident eosinophils. Commun Biol. 2019,2:181. doi: 10.1038/s42003-019-0425-3

Cheung K, Ma L, Wang G, et al. CD31 signals confer immune privilege to the vascular endothelium. Proc Natl Acad Sci U S A. 2015,112(43):E5815-24. doi: 10.1073/pnas.1509627112

Greineder CF, Chacko AM, Zaytsev S, et al. Vascular immunotargeting to endothelial determinant ICAM-1 enables optimal partnering of recombinant scFv-thrombomodulin fusion with endogenous cofactor. PLoS One. 2013,8(11):e80110. doi: 10.1371/journal.pone.0080110

DeLisser HM, Christofidou-Solomidou M, Strieter RM, et al. Involvement of endothelial PECAM-1/CD31 in angiogenesis. Am J Pathol. 1997,151(3):671-7.

Baldwin HS, Shen HM, Yan HC, et al. Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31): alternatively spliced, functionally distinct isoforms expressed during mammalian cardiovascular development. Development. 1994,120(9):2539-53.